Real-world data on the effect of long-term treatment with nusinersen over > 4 years in a cohort of Swiss patients with spinal muscular atrophy | Synapse
March 3, 2026Open Access
Real-world data on the effect of long-term treatment with nusinersen over > 4 years in a cohort of Swiss patients with spinal muscular atrophy
Key Points
Patients showed sustained improvement in motor function after long-term treatment with nusinersen, indicating therapeutic value.
The study analyzed real-world data from Swiss patients over more than four years, covering treatment outcomes and health metrics.
Assessment involved tracking changes in motor skills and function, focusing on the impact of sustained nusinersen therapy.
The findings highlight the importance of long-term treatment strategies in managing spinal muscular atrophy and improving quality of life.